NCT05701007 2026-01-29Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in FinlandPfizerCompleted1,083 enrolled 29 charts
NCT03209518 2019-11-01Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"TakedaCompleted312 enrolled 17 charts
NCT03209492 2019-04-11Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer"TakedaCompleted333 enrolled 16 charts
NCT02167893 2017-03-29Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey "Long-term Use Survey in Prostate Cancer Patients (96 Weeks)"TakedaCompleted11,288 enrolled 17 charts
NCT02134977 2016-10-18Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients"TakedaCompleted2,816 enrolled 29 charts
NCT02154139 2016-02-17Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"TakedaCompleted651 enrolled 12 charts
NCT01081873 2012-10-31Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate CancerAbbottCompleted2,717 enrolled 22 charts